The impact of direct oral anticoagulants on viscoelastic testing–A systematic review
SD Sahli, C Castellucci, TR Roche, J Rössler… - Frontiers in …, 2022 - frontiersin.org
Background In case of bleeding patients and in acute care, the assessment of residual direct
oral anticoagulant (DOAC) activity is essential for evaluating the potential impact on …
oral anticoagulant (DOAC) activity is essential for evaluating the potential impact on …
“In less than no time”: feasibility of rotational thromboelastometry to detect anticoagulant drugs activity and to guide reversal therapy
V Pavoni, L Gianesello, D Conti, P Ballo… - Journal of Clinical …, 2022 - mdpi.com
Anticoagulant drugs (ie, unfractionated heparin, low-molecular-weight heparins, vitamin K
antagonists, and direct oral anticoagulants) are widely employed in preventing and treating …
antagonists, and direct oral anticoagulants) are widely employed in preventing and treating …
Using pharmacogenetics of direct oral anticoagulants to predict changes in their pharmacokinetics and the risk of adverse drug reactions
NA Shnayder, MM Petrova, PA Shesternya… - Biomedicines, 2021 - mdpi.com
Dabigatran, rivaroxaban, apixaban, and edoxaban are direct oral anticoagulants (DOACs)
that are increasingly used worldwide. Taking into account their widespread use for the …
that are increasingly used worldwide. Taking into account their widespread use for the …
[HTML][HTML] Early goal-directed hemostatic therapy for severe acute bleeding management in the intensive care unit: a narrative review
T Crochemore, K Görlinger, MD Lance - Anesthesia & Analgesia, 2024 - journals.lww.com
This is a narrative review of the published evidence for bleeding management in critically ill
patients in different clinical settings in the intensive care unit (ICU). We aimed to describe …
patients in different clinical settings in the intensive care unit (ICU). We aimed to describe …
Real-time detection and differentiation of direct oral anticoagulants (rivaroxaban and dabigatran) using modified thromboelastometric reagents
ST Schäfer, T Wiederkehr, T Kammerer… - Thrombosis …, 2020 - Elsevier
Introduction Timely measurement of direct oral anticoagulants (DOACs) is challenging,
though clinically important. We tested the hypotheses, that thromboelastometry is able to …
though clinically important. We tested the hypotheses, that thromboelastometry is able to …
[HTML][HTML] Rapid determination of anticoagulating effects of dabigatran in whole blood with rotational thromboelastometry and a thrombin‐based trigger
V Taune, M Skeppholm, A Ågren, G Gryfelt… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• A rapid test to detect thrombin inhibition by dabigatran would be valuable in
acute situations.• A thrombin‐based trigger was applied in whole blood using rotation …
acute situations.• A thrombin‐based trigger was applied in whole blood using rotation …
Impact of dabigatran treatment on rotation thromboelastometry
J Sokol, F Nehaj, J Ivankova, M Mokan… - Clinical and Applied …, 2021 - journals.sagepub.com
A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated
patients with uncontrolled bleeding or before acute surgery. The aim of this study was to …
patients with uncontrolled bleeding or before acute surgery. The aim of this study was to …
Rotational thromboelastometry (ROTEM®)
K Görlinger, D Dirkmann, AA Hanke - Trauma induced coagulopathy, 2021 - Springer
Thromboelastometry (ROTEM®) is an advancement of the classical thromboelastography.
Several technical enhancements made already the semiautomated ROTEM® delta device …
Several technical enhancements made already the semiautomated ROTEM® delta device …
Whole blood point-of-care testing for incomplete reversal with idarucizumab in supratherapeutic dabigatran
S Takeshita, KA Tanaka, T Sawa, M Sanda… - Anesthesia & …, 2020 - journals.lww.com
BACKGROUND: Incomplete reversal with a recommended 5-g dose of idarucizumab has
been reported in patients with excessively high dabigatran concentrations. A timely …
been reported in patients with excessively high dabigatran concentrations. A timely …
Gene polymorphism as a cause of hemorrhagic complications in patients with non-valvular atrial fibrillation treated with oral vitamin K-independent anticoagulants
A Abdrakhmanov, A Shaimerdinova… - Therapeutic …, 2024 - journals.sagepub.com
Atrial fibrillation (AF) accounts for 40% of all cardiac arrhythmias and is associated with a
high risk of stroke and systemic thromboembolic complications. Dabigatran, rivaroxaban …
high risk of stroke and systemic thromboembolic complications. Dabigatran, rivaroxaban …